These results do not apply to compounded versions of GLP-1 drugs, which are not FDA-approved and have not been evaluated for safety, effectiveness, or quality
Our pharmacy option allows you to claim back 50% of prescribed medicines up to 200 per year
Rising demand for effective weight reduction strategies and improved glycemic control, especially in regions facing surging rates of metabolic disorders, is a key factor driving market expansion
Vitamin B12 injections are commonly used to support energy levels, red blood cell production, and nervous system health
Glucagon-like peptide-1 receptor agonists: A new option for weight management
Limited evidence from research in men with type 2 diabetes and obesity suggests that weight loss and improved metabolic control associated with GLP-1 agonist therapy may correlate with improvements in erectile function and sexual satisfaction